BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37265221)

  • 1. Updating germ cell tumour pathogenesis - the ability of seminomas for FOXA2-driven extra-embryonic differentiation.
    Bremmer F; Lubk L; Ströbel P; Nettersheim D
    Histopathology; 2023 Sep; 83(3):477-481. PubMed ID: 37265221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The plasticity of germ cell cancers and its dependence on the cellular microenvironment.
    Nettersheim D; Schorle H
    J Cell Mol Med; 2017 Aug; 21(8):1463-1467. PubMed ID: 28244655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β1, EGF and FGF4 synergistically induce differentiation of the seminoma cell line TCam-2 into a cell type resembling mixed non-seminoma.
    Nettersheim D; Gillis AJ; Looijenga LH; Schorle H
    Int J Androl; 2011 Aug; 34(4 Pt 2):e189-203. PubMed ID: 21649665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of testicular germ cell tumours.
    Looijenga LH; Oosterhuis JW
    Rev Reprod; 1999 May; 4(2):90-100. PubMed ID: 10357096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCam-2 Cells Deficient for SOX2 and FOXA2 Are Blocked in Differentiation and Maintain a Seminoma-Like Cell Fate In Vivo.
    Nettersheim D; Vadder S; Jostes S; Heimsoeth A; Schorle H
    Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31130628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis.
    Gillis AJ; Stoop H; Biermann K; van Gurp RJ; Swartzman E; Cribbes S; Ferlinz A; Shannon M; Oosterhuis JW; Looijenga LH
    Int J Androl; 2011 Aug; 34(4 Pt 2):e160-74. PubMed ID: 21631526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleolin and nucleophosmin expression in seminomas and non-seminomatous testicular tumors.
    Masiuk M; Lewandowska M; Teresinski L; Dobak E; Urasinska E
    Folia Histochem Cytobiol; 2019; 57(3):139-145. PubMed ID: 31513277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA-binding protein LIN28 is a marker for testicular germ cell tumors.
    Cao D; Allan RW; Cheng L; Peng Y; Guo CC; Dahiya N; Akhi S; Li J
    Hum Pathol; 2011 May; 42(5):710-8. PubMed ID: 21288558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated status of tumour-infiltrating lymphocytes and apoptosis in testicular seminoma.
    Yakirevich E; Lefel O; Sova Y; Stein A; Cohen O; Izhak OB; Resnick MB
    J Pathol; 2002 Jan; 196(1):67-75. PubMed ID: 11748644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycolipids of human primary testicular germ cell tumours.
    Olie RA; Fenderson B; Daley K; Oosterhuis JW; Murphy J; Looijenga LH
    Br J Cancer; 1996 Jul; 74(1):133-40. PubMed ID: 8679447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pitfalls in the interpretation of specimens from patients with testicular tumours, with an emphasis on variant morphologies.
    Ulbright TM
    Pathology; 2018 Jan; 50(1):88-99. PubMed ID: 29129333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas.
    Nettersheim D; Arndt I; Sharma R; Riesenberg S; Jostes S; Schneider S; Hölzel M; Kristiansen G; Schorle H
    Br J Cancer; 2016 Aug; 115(4):454-64. PubMed ID: 27441500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput microRNAome analysis in human germ cell tumours.
    Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW; Sun Y; Chen C; Guenther S; Sherlock J; Veltman I; Baeten J; van der Spek PJ; de Alarcon P; Looijenga LH
    J Pathol; 2007 Nov; 213(3):319-28. PubMed ID: 17893849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D2-40 immunohistochemistry in the differential diagnosis of seminoma and embryonal carcinoma: a comparative immunohistochemical study with KIT (CD117) and CD30.
    Lau SK; Weiss LM; Chu PG
    Mod Pathol; 2007 Mar; 20(3):320-5. PubMed ID: 17277761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the Fas/FasL pathway in the pathogenesis of germ cell tumours of the adult testis.
    Kersemaekers AM; van Weeren PC; Oosterhuis JW; Looijenga LH
    J Pathol; 2002 Apr; 196(4):423-9. PubMed ID: 11920738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome X-encoded Cancer/Testis antigens are less frequently expressed in non-seminomatous germ cell tumors than in seminomas.
    Chen YT; Cao D; Chiu R; Lee P
    Cancer Immun; 2013; 13():10. PubMed ID: 23885216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in testicular germ cell tumor research.
    van de Geijn GJ; Hersmus R; Looijenga LH
    Birth Defects Res C Embryo Today; 2009 Mar; 87(1):96-113. PubMed ID: 19306344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression.
    Nettersheim D; Gillis A; Biermann K; Looijenga LH; Schorle H
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1033-42. PubMed ID: 21987446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of monoclonal antibody 43-9F in testicular germ cell tumours.
    Heidenreich A; Sesterhenn IA; Mostofi FK; Moul JW
    Int J Androl; 1998 Oct; 21(5):283-8. PubMed ID: 9805244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.